MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0009489
Seraphim Pharmaceuticals Private Limited
Seraphim Pharmaceuticals Private Limited - healthcare in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹16.55 Lakh
▼ 54% YoY
Net loss · FY 2025
₹6.52 Lakh
Net margin -39.4%
EBITDA · FY 2025
-₹6.52 Lakh
EBITDA margin -39.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Seraphim Pharmaceuticals Private Limited
Data last updated:
Seraphim Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 04 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2021PTC381954.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shrey Kumar and Jagwati Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop At 329 Plot No – 2 T/F Vardhman Crown Mall Sec 19 Dwk, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.55 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹6.52 Lakh (net margin -39.4%) and EBITDA of -₹6.52 Lakh (EBITDA margin -39.4%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years.
Seraphim Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0009489).
Company details
CIN U33100DL2021PTC381954
Registration Number 381954
Incorporation Date 04 June 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0009489
Key People
Shrey Kumar Director Jagwati Singh Director Recognitions & Rankings of Seraphim Pharmaceuticals
Contact details
Seraphim Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressShop At 329 Plot No – 2 T/F Vardhman Crown Mall Sec 19 Dwk, New Delhi, Delhi, India – 110075
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing
Comprehensive company report
Seraphim Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Seraphim Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Seraphim Pharmaceuticals Private Limited, buy the company report.
Financials of Seraphim Pharmaceuticals Private Limited
FY 2025 filings availableSeraphim Pharmaceuticals Private Limited reported revenue of ₹16.55 Lakh (down 54% YoY) for FY 2025.
Revenue · FY 2025
₹16.55 Lakh ▼ 54%
Net loss · FY 2025
₹6.52 Lakh margin -39.4%
EBITDA · FY 2025
-₹6.52 Lakh margin -39.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 54%
3 years · compounded
▼ 22%
EBITDA CAGR growth
3 years · compounded
▼ 155%
Revenue has declined at a compounded annual rate (CAGR) of 22% over three years, including a 54% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹6.52 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹6.52 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -39.4% | |||
| Net Profit Margin | -39.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Seraphim Pharmaceuticals Private Limited, buy the company report.
Board of directors of Seraphim Pharmaceuticals Private Limited
Seraphim Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrey Kumar Also directs: Medily Healthcare Private Limited | Director | 04 Jun 2021 | 5 Years 4 Months | Current |
| Jagwati Singh | Director | 04 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Seraphim Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amaresha Pharmaceuticals Private Limited | ₹16.64 Lakh (FY 2024) | 13.0% | Chennai, Tamil Nadu, India | |||
| Rupison Pharmaceuticals Private Limited | ₹16.61 Lakh (FY 2025) | 24.0% | Agra, Uttar Pradesh, India | |||
| Seraphim Pharmaceuticals Private Limitedthis company | ₹16.55 Lakh (FY 2025) | -₹6.52 Lakh | -39.4% | -54.0% | New Delhi, Delhi, India | |
| Ramington Pharmaceuticals Private Limited | ₹16.55 Lakh (FY 2025) | 3.0% | Ambala Cantt, Haryana, India | |||
| Altruistic Pharmaceuticals (OPC) Private Limited | ₹16.54 Lakh (FY 2025) | 90.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Seraphim Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Seraphim Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seraphim Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Seraphim Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Seraphim Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Jagwati Singh was appointed as Director on 04 Jun 2021.
AGM
Seraphim Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Seraphim Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Jagwati Singh was appointed as Director.
Appointed
Shrey Kumar was appointed as Director.
Incorporation
04 Jun 2021
Seraphim Pharmaceuticals Private Limited was registered on 04 Jun 2021 with Roc Delhi & aged 5 years 4 months as per MCA records.
Frequently asked questions
Seraphim Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 04 June 2021 (5+ years old) and is registered under CIN U33100DL2021PTC381954.
Seraphim Pharmaceuticals has 2 current directors:
- Shrey Kumar - Director
- Jagwati Singh - Director
The latest financial statements of Seraphim Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Seraphim Pharmaceuticals is U33100DL2021PTC381954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seraphim Pharmaceuticals was incorporated on 04 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Seraphim Pharmaceuticals by revenue are Amaresha Pharmaceuticals Private Limited, Rupison Pharmaceuticals Private Limited, Ramington Pharmaceuticals Private Limited, Altruistic Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jagwati Singh was appointed as Director on 04 Jun 2021. Shrey Kumar was appointed as Director on 04 Jun 2021.
Yes, Seraphim Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0009489).
The registered office of Seraphim Pharmaceuticals is at Shop At 329 Plot No – 2 TF Vardhman Crown Mall Sec 19 Dwk, New Delhi, Delhi, India – 110075.
Seraphim Pharmaceuticals operates in the healthcare industry, in the medical appliances and instruments segment.
Seraphim Pharmaceuticals can be reached at its registered office: Shop At 329 Plot No – 2 TF Vardhman Crown Mall Sec 19 Dwk, New Delhi, Delhi, India – 110075.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages